IL-22 inhibitors to treat inflammatory disorders such as arthritis

Author：

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.13, Iss.3, 2003-03, pp. : 373-375

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pathophysiological roles for IL-18 in inflammatory arthritis

By Matsui Kiyoshi Tsutsui Hiroko Nakanishi Kenji

Expert Opinion on Therapeutic Targets, Vol. 7, Iss. 6, 2003-12 ,pp. : 701-724

Informa Healthcare

Access to resources Recommend Favorite

Development of aldose reductase inhibitors for the treatment of inflammatory disorders

By Chatzopoulou Maria Pegklidou Kyriaki Papastavrou Nikolaos Demopoulos Vassilis J

Expert Opinion on Drug Discovery, Vol. 8, Iss. 11, 2013-11 ,pp. : 1365-1380

Informa Healthcare

Access to resources Recommend Favorite

Rho Kinase (ROCK) Inhibitors and Their Application to Inflammatory Disorders

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 8, 2009-05 ,pp. : 704-723

Bentham Science Publishers

Access to resources Recommend Favorite

IL-1 inhibitors: novel agents in the treatment of rheumatoid arthritis

By Gabay C.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 1, 2000-01 ,pp. : 113-127

Informa Healthcare

Access to resources Recommend Favorite

IL-22 and Its Receptors, New Players in the Inflammatory Network

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 5, Iss. 3, 2006-08 ,pp. : 251-257

Bentham Science Publishers

Access to resources Recommend Favorite